A 'fit' microbiota to potentiate cancer immunotherapy

Maria Rescigno

doi:10.1186/s13073-015-0256-x

A 'fit' microbiota to potentiate cancer immunotherapy

Maria Rescigno

Istituto Europeo di Oncologia

Research output: Contribution to journal › Article › peer-review

Abstract

Cancer immunotherapy is very effective and leads to a long-term response in certain patients. Yet, the variability observed in this response indicates that additional factors related to the host must influence the activity of the treatments. Recent research suggests that the microbiota might play an important part in this variability.

Original language	English
Article number	131
Journal	Genome Medicine
Volume	7
Issue number	1
DOIs	https://doi.org/10.1186/s13073-015-0256-x
Publication status	Published - Dec 21 2015

ASJC Scopus subject areas

Genetics(clinical)
Genetics
Molecular Biology
Molecular Medicine

Access to Document

10.1186/s13073-015-0256-x

Fingerprint Dive into the research topics of 'A 'fit' microbiota to potentiate cancer immunotherapy'. Together they form a unique fingerprint.

Cite this

@article{229d991211c94ad989279573d4dc8d88,

title = "A 'fit' microbiota to potentiate cancer immunotherapy",

abstract = "Cancer immunotherapy is very effective and leads to a long-term response in certain patients. Yet, the variability observed in this response indicates that additional factors related to the host must influence the activity of the treatments. Recent research suggests that the microbiota might play an important part in this variability.",

author = "Maria Rescigno",

year = "2015",

month = dec,

day = "21",

doi = "10.1186/s13073-015-0256-x",

language = "English",

volume = "7",

journal = "Genome Medicine",

issn = "1756-994X",

publisher = "BioMed Central Ltd.",

number = "1",

}

TY - JOUR

T1 - A 'fit' microbiota to potentiate cancer immunotherapy

AU - Rescigno, Maria

PY - 2015/12/21

Y1 - 2015/12/21

N2 - Cancer immunotherapy is very effective and leads to a long-term response in certain patients. Yet, the variability observed in this response indicates that additional factors related to the host must influence the activity of the treatments. Recent research suggests that the microbiota might play an important part in this variability.

AB - Cancer immunotherapy is very effective and leads to a long-term response in certain patients. Yet, the variability observed in this response indicates that additional factors related to the host must influence the activity of the treatments. Recent research suggests that the microbiota might play an important part in this variability.

UR - http://www.scopus.com/inward/record.url?scp=84952883106&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952883106&partnerID=8YFLogxK

U2 - 10.1186/s13073-015-0256-x

DO - 10.1186/s13073-015-0256-x

M3 - Article

AN - SCOPUS:84952883106

VL - 7

JO - Genome Medicine

JF - Genome Medicine

SN - 1756-994X

IS - 1

M1 - 131

ER -